help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Marx, S. J.
Right arrow Articles by Cole, D. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Marx, S. J.
Right arrow Articles by Cole, D. E.

Journal of Clinical Endocrinology & Metabolism, Vol 62, 445-449, Copyright © 1986 by Endocrine Society

ARTICLES

Secretory dysfunction in parathyroid cells from a neonate with severe primary hyperparathyroidism

SJ Marx, RD Lasker, EM Brown, LA Fitzpatrick, NB Sweezey, RB Goldbloom, DA Gillis and DE Cole

We report a patient with neonatal severe primary hyperparathyroidism whose parathyroid cells were markedly refractory to regulation by calcium in vitro. He showed life-threatening hypercalcemia (4.8-5.2 mM vs. normal of 2.1-2.7 mM). A sibling had been treated previously for an identical disorder. At age 6.5 months, four hyperplastic parathyroid glands were removed, and portions of one were immediately grafted into the forearm. Serum calcium again became elevated post-operatively and then fall to the normal range after excision of grafted parathyroid tissue. Dispersed parathyroid cells from the first operation showed no suppression of PTH secretion by 2 mM calcium; however, there was normal maximal suppressibility at 4 mM calcium with half-maximal suppression at 2.53 mM (the calcium set point). This contrasts with much lower set points previously established for suppressible cells from normal (1.02 +/- 0.10 mM, mean +/- 1 SD), from primary hyperplastic (1.10 +/- 0.14 mM), or from adenomatous (1.26 +/- 0.14 mM) parathyroid glands. The strikingly high set point may not be unique because a small number of glands previously classified as nonsuppressible (by the criterion of failing to suppress below 50% maximum at calcium concentration up to 2- 3 mM) might have shown similarly high set points if tested at higher calcium concentrations. We conclude that an unusual abnormality of PTH secretory control accounts, in large part, for both the marked hypercalcemia and for its refractoriness to surgical treatment in this patient.


This article has been cited by other articles:


Home page
 J. Clin. Endocrinol. Metab.Home page
F. Cetani, A. Picone, P. Cerrai, E. Vignali, S. Borsari, E. Pardi, P. Viacava, A. G. Naccarato, P. Miccoli, O. Kifor, et al.
Parathyroid Expression of Calcium-Sensing Receptor Protein and in Vivo Parathyroid Hormone-Ca2+ Set-Point in Patients with Primary Hyperparathyroidism
J. Clin. Endocrinol. Metab., December 1, 2000; 85(12): 4789 - 4794.
[Abstract] [Full Text]

Home page
 J. Clin. Endocrinol. Metab.Home page
S. J. Marx
CLINICAL REVIEW 109: Contrasting Paradigms for Hereditary Hyperfunction of Endocrine Cells
J. Clin. Endocrinol. Metab., September 1, 1999; 84(9): 3001 - 3009.
[Full Text]

Home page
 NEJMHome page
E. M. Brown, M. Pollak, C. E. Seidman, J.G. Seidman, Y.-H. W. Chou, D. Riccardi, and S. C. Hebert
Calcium-Ion-Sensing Cell-Surface Receptors
N. Engl. J. Med., July 27, 1995; 333(4): 234 - 240.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1986 by The Endocrine Society